Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding

Regulatory Peptides

Volumn 130, Issue 1-2, 2005, Pages 7-13

  Heinonen, M V ^a   Purhonen, A K ^a   Miettinen, P ^a   Paakkonen M ^a   Pirinen, E ^a   Alhava, E ^a   Akerman K ^a   Herzig, K H ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apelin; Gastrointestinal peptides; Leptin; Morbid obesity; Orexin A

Indexed keywords

APELIN; LEPTIN; OREXIN A; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GASTRIC BANDING; HUMAN; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL TRACT; GASTROPLASTY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; NEUROPEPTIDES; OBESITY, MORBID; STOMACH; TIME FACTORS; WEIGHT LOSS;

EID: 22044453852     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.05.003     Document Type: Article

References (48)

1. R.E. Brolin Bariatric surgery and long-term control of morbid obesity JAMA 288 2002 2793 2796
2. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, and M.X. Zou Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochem Biophys Res Commun 251 1998 471 476
3. Y. Habata, R. Fujii, M. Hosoya, S. Fukusumi, Y. Kawamata, and S. Hinuma Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum Biochim Biophys Acta 1452 1999 25 35
4. Y. Kawamata, Y. Habata, S. Fukusumi, M. Hosoya, R. Fujii, and S. Hinuma Molecular properties of apelin: tissue distribution and receptor binding Biochim Biophys Acta 1538 2001 162 171
5. N. De Mota, Z. Lenkei, and C. Llorens-Cortes Cloning, pharmacological characterization and brain distribution of the rat apelin receptor Neuroendocrinology 72 2000 400 407
6. A.M. O'Carroll, T.L. Selby, M. Palkovits, and S.J. Lolait Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues Biochim Biophys Acta 1492 2000 72 80
7. M. De Falco, L. De Luca, N. Onori, I. Cavallotti, F. Artigiano, and V. Esposito Apelin expression in normal human tissues In Vivo 16 2002 333 336
8. D. Sunter, A.K. Hewson, and S.L. Dickson Intracerebroventricular injection of apelin-13 reduces food intake in the rat Neurosci Lett 353 2003 1 4
9. M. O'Shea, M.J. Hansen, K. Tatemoto, and M.J. Morris Inhibitory effect of apelin-12 on nocturnal food intake in the rat Nutr Neurosci 6 2003 163 167
10. J.P. Kukkonen, T. Holmqvist, S. Ammoun, and K.E. Akerman Functions of the orexinergic/hypocretinergic system Am J Physiol Cell Physiol 283 2002 1567 1591
11. A.L. Kirchgessner, and M. Liu Orexin synthesis and response in the gut Neuron 24 1999 941 951
12. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R.M. Chemelli, and H. Tanaka Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92 1998 573 585
13. M.G. Dube, S.P. Kalra, and P.S. Kalra Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action Brain Res 842 1999 473 477
14. M. Lubkin, and A. Stricker-Krongrad Independent feeding and metabolic actions of orexins in mice Biochem Biophys Res Commun 253 1998 241 245
15. C.M. Edwards, S. Abusnana, D. Sunter, K.G. Murphy, M.A. Ghatei, and S.R. Bloom The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin J Endocrinol 160 1999 R7 R12
16. H. Yamada, T. Okumura, W. Motomura, Y. Kobayashi, and Y. Kohgo Inhibition of food intake by central injection of anti-orexin antibody in fasted rats Biochem Biophys Res Commun 267 2000 527 531
17. A.C. Haynes, B. Jackson, H. Chapman, M. Tadayyon, A. Johns, and R.A. Porter A selective orexin-1 receptor antagonist reduces food consumption in male and female rats Regul Pept 96 2000 45 51
18. S. Blüher, and C.S. Mantzoros The Role of leptin in regulating neuroendocrine function in humans J Nutr 134 2004 2469S 2474S
19. R. Matyjek, K.H. Herzig, S. Kato, and R. Zabielski Exogenous leptin inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats Regul Pept 114 2003 15 20
20. J. Himms-Hagen Physiological roles of the leptin endocrine system: differences between mice and humans Crit Rev Clin Lab Sci 36 1999 575 655
21. R.S. Ahima, and J.S. Flier Leptin Annu Rev Physiol 62 2000 413 437
22. L. Kuzmak Gastric banding M. Deitel Surgery for the morbidly obese patient 1989 Lea & Feibinger Philadelphia 225 259
23. T. Martikainen, E. Pirinen, E. Alhava, E. Poikolainen, M. Paakkonen, and M. Uusitupa Long-term results, late complications and quality of life in a series of adjustable gastric banding Obes Surg 14 2004 648 654
24. A.J. Kastin, and V. Akerstrom Orexin A but not orexin B rapidly enters brain from blood by simple diffusion J Pharmacol Exp Ther 289 1999 219 223
25. A.J. Kastin, and W. Pan Dynamic regulation of leptin entry into brain by the blood-brain barrier Regul Pept 92 2000 37 43
26. S. Taheri, K. Murphy, M. Cohen, E. Sujkovic, A. Kennedy, and W. Dhillo The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats Biochem Biophys Res Commun 291 2002 1208 1212
27. K. Tatemoto, K. Takayama, M.X. Zou, I. Kumaki, W. Zhang, and K. Kumano The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism Regul Pept 99 2001 87 92
28. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, and A. Mazzucotelli Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764 1771
29. G. Foldes, F. Horkay, I. Szokodi, O. Vuolteenaho, M. Ilves, and K.A. Lindstedt Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure Biochem Biophys Res Commun 308 2003 480 485
30. M.M. Chen, E.A. Ashley, D.X. Deng, A. Tsalenko, A. Deng, and R. Tabibiazar Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction Circulation 108 2003 1432 1439
31. J.A. Adam, P.P. Menheere, F.M. van Dielen, P.B. Soeters, W.A. Buurman, and J.W. Greve Decreased plasma orexin-A levels in obese individuals Int J Obes Relat Metab Disord 26 2002 274 276
32. P.J. Tomasik, M. Spodaryk, and K. Sztefko Plasma concentrations of orexins in children Ann Nutr Metab 48 2004 215 220
33. C.B. Saper, T.C. Chou, and T.E. Scammell The sleep switch: hypothalamic control of sleep and wakefulness Trends Neurosci 24 2001 726 731
34. R.M. Chemelli, J.T. Willie, C.M. Sinton, J.K. Elmquist, T. Scammell, and C. Lee Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 98 1999 437 451
35. E. Mignot Sleep, sleep disorders and hypocretin (orexin) Sleep Med 5 Suppl 1 2004 S2 S8
36. T. Nishijima, S. Sakurai, Z. Arihara, and K. Takahashi Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome Peptides 24 2003 407 411
37. N. Igarashi, K. Tatsumi, A. Nakamura, S. Sakao, Y. Takiguchi, and T. Nishikawa Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome Chest 124 2003 1381 1385
38. S. Higuchi, A. Usui, M. Murasaki, S. Matsushita, N. Nishioka, and A. Yoshino Plasma orexin-A is lower in patients with narcolepsy Neurosci Lett 318 2002 61 64
39. X. Busquets, F. Barbe, A. Barcelo, M. de la Pena, N. Sigritz, and L.R. Mayoralas Decreased plasma levels of orexin-A in sleep apnea Respiration 71 2004 575 579
40. J. Lin, G.T. Yan, X.H. Hao, K. Zhang, L.H. Wang, and H. Xue Establishment and primary application of a highly-sensitive orexin-A radioimmunoassay J Immunoassay Immunochem 25 2004 45 55
41. G. Komaki, Y. Matsumoto, H. Nishikata, K. Kawai, T. Nozaki, and M. Takii Orexin-A and leptin change inversely in fasting non-obese subjects Eur J Endocrinol 144 2001 645 651
42. B. Zheng, J. Eng, and R.S. Yalow Brain/gut peptides in fed and fasted rats Endocrinology 120 1987 714 717
43. M. Ehrstrom, T. Gustafsson, A. Finn, A. Kirchgessner, P. Gryback, H. Jacobsson, P. Hellstrom, and E. Naslund Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin and the distribution of orexin and orexin receptors in the gut and pancreas in man J Clin Endocrinol Metab 90 2005 2370 2377
44. G. Burdyga, S. Lal, D. Spiller, W. Jiang, D. Thompson, and S. Attwood Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans Gastroenterology 124 2003 129 139
45. M.W. Schwartz, S.C. Woods, D. Porte Jr., R.J. Seeley, and D.G. Baskin Central nervous system control of food intake Nature 404 2000 661 671
46. M. Maffei, J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, and Y. Zhang Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat Med 1 1995 1155 1161
47. D. Infanger, R. Baldinger, R. Branson, T. Barbier, R. Steffen, and F.F. Horber Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects Obes Surg 13 2003 879 888
48. B. Geloneze, M.A. Tambascia, J.C. Pareja, E.M. Repetto, L.A. Magna, and S.G. Pereira Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes Obes Surg 11 2001 693 698